ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: NBCC Urges Funding For Treatment Of Women Screened In CDC Program

July 17, 1998

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

September 13, 2013

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

Expiring Program Offer Flexibility

February 12, 1982

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

Funding Opportunities: Komen Foundation Seeks Reviewers

February 28, 1997